Author:
Wilms Annika,Meier Robin,Kleinebudde Peter
Abstract
Abstract
Purpose
Roll compaction/dry granulation is established in manufacturing of solid oral dosage forms and, within the context of continuous manufacturing, it has sparked interest as material is fed, processed, and ejected continuously while also providing large possible throughputs. However, this amount of material has to be adequately controlled in real time to assure quality.
Methods
This research aimed at monitoring the critical quality attribute granule size distribution in continuous roll compaction/dry granulation (QbCon®; L.B. Bohle, Ennigerloh, Germany) using in-line and on-line laser diffraction. The influence of varying process parameters and excipient formulations was studied and evaluated with the prospect of using this technique to develop control loops. For this purpose, residence time parameters were assessed. In- and on-line data was compared with off-line laser diffraction and dynamic image analysis data.
Results
The system successfully monitored the granule size distribution in a variety of process parameters and throughputs (up to 27.5 kg/h). It was sensitive to changes in process parameters and changes in material blends, which could pose a potential threat to the final drug products’ quality. Average event propagation time from the compaction zone to the laser diffraction system of 17.7 s demonstrates the systems’ fast reaction time.
Conclusion
Results highlight laser diffraction as a valuable method of in- and on-line size determination and allow for the development of a control strategy using this principle.
Funder
Heinrich-Heine-Universität Düsseldorf
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Reference39 articles.
1. Plumb K. Continuous processing in the pharmaceutical industry - changing the mind set. Chem Eng Res Des. 2005;83(A6):730–8. https://doi.org/10.1205/cherd.04359.
2. Rantanen J, Khinast J. The future of pharmaceutical manufacturing sciences. J Pharm Sci. 2015;104(11):3612–38. https://doi.org/10.1002/jps.24594.
3. Lee SL. Current FDA Perspective for Continuous Manufacturing. US FDA Center for Drug Evaluation and Research, MIT-CMAC 2nd International Symposium on Continuous Manufacturing of Pharmaceuticals. 2016. http://iscmp.mit.edu/sites/default/files/documents/ISCMP%202016%20-%20FDA%20MIT-CMAC%20for%20CM%202016%20Ver6.pdf.
4. Lee SL, O’Connor TF, Yang XC, Cruz CN, Chatterjee S, Madurawe RD, et al. Modernizing pharmaceutical manufacturing: from batch to continuous production. J Pharm Innov. 2015;10(3):191–9. https://doi.org/10.1007/s12247-015-9215-8.
5. Lee SL. Quality Considerations for Continuous Manufacturing Guidance for Industry. Food and Drug Administration, Silver Spring. 2019. https://www.fda.gov/media/121314/download. Accessed 14.11.2019 14:48.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献